Invest in cancer diagnostic technology
Lazarus Sauti
In countries within and across Africa, cancer is a
growing health burden that is ravaging societies.
The diseases can no longer be ignored as it is killing more people globally than Human Immunodefiency Virus/Acquired
Immune Deficiency Syndrome, Tuberculosis and malaria.
The World Health Organisation, a specialised agency of the United Nations
that is concerned with international public health, agrees that cancer figures
among the leading causes of death worldwide, accounting for 8.2 million deaths
in 2012.
Further, the leading international
public health organisation forecasts that the annual cancer cases will rise to
22 million within the next two decades from 14 million in 2012.
Through its cancer research
agency, International Agency for Research on Cancer, the World Health
Organisation also asserts that lung, liver, stomach, colorectal and breast
cancers cause the most cancer deaths each year.
This means cancer
requires urgent attention before it grounds Africa to her knees.
Sadly, in most – if not
all – African countries, cancer services are failing to meet growing demand due
to lack of adequate equipment as well as decades of under-investment especially
in health services.
Dr. Ahmed Komen, a
Kenyan oncologist at Aga khan University Hospital, Nairobi, believes this poor investment
in diagnostic technologies is seriously hampering the treatment of cancer and
the much needed attention it demands.
“Due to lack of modern
diagnostic technologies, the disease is not detected and diagnosed early, and
most citizens, especially women, are suffering as a result,” says Dr. Komen.
He goes on to say
cancer diagnosis, consequently, needs to be made on time if Africa is to save
her citizenry.
“Cancer is curable and,
therefore, early detection
of any type of it is crucial to treatment and management of the disease,” he
notes, adding that the disease is serious hence diagnosis needs
to be made on time.
Dr. Komen also adds
that cervical cancer – a burden for many women in African communities, for
instance, can be largely avoided with a vaccine or successfully treated if it
is detected and diagnosed early enough.
Because of this, David Makumi of the Kenya Cancer Association,
says countries within and across the African continent must invest heavily in
cancer diagnostic technology to improve the treatment and care of growing
cancer patients on the continent.
“Investing in cancer
diagnostic technologies is critical for African countries. It will help reduce
the overlapping burden of the disease,” he says.
Dr. Shahin Sayed, a
pathologist at the Aga Khan University Hospital, also agrees that the
successful management of cancer depends on effective cancer diagnostic technologies.
“Efforts to combat cancer, without doubt, depend on
effective cancer diagnostic technologies. Per se, African
countries need to invest more in such technologies as well as in laboratory
infrastructure to enhance access to, prevention, diagnosis, treatment, care and
research of the disease,” says Dr. Sayed.
The medical doctor also
asserts that the effective management of cancer in Africa warrants translational efforts to develop
appropriate cancer diagnostic technologies that could help improve treatment of
the disease.
Countries in the
continent, therefore, need to scale up strategies for tackling cancer by developing suitable cancer
diagnostic technologies, increasing the number of healthcare
personnel, providing more equipment for cancer care on top of modernising
cancer treatment and care to meet global standards.
For this to be
successful, Makumi urges stakeholders from the community, government as well as
the private sector to work together in fight for cancer.
“For proper cancer treatment and management, all stakeholders
from the community, government and private sector must work together in fight
for cancer,” he advices.
Frankly, early detection and diagnosis of cancer
as well as minimally invasive treatments are more likely to yield successful
outcomes in the fight for the disease.
Accordingly, African
countries, as a matter of necessity, must invest in the development of low-cost
and portable diagnostic technologies, which have the potential to increase
early detection, diagnosis, and non- or minimally-invasive treatment of the
disease.
Comments
Post a Comment